Liquidia Corp (LQDA) Latest Filing Signal
Cross-checked across multiple AI analysts and grounded in the latest SEC filing.
powered by: earningsVibe.ai
Question:
What is the latest filing signal for Liquidia Corp?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest
10-K, Liquidia Corp's filing signal
turned positive.
earningsVibe SuperAnalyst™ Verdict:
TURNED POSITIVE
Signal Performance — Stock Price Since Filing
30-Day Change
+9.07%
from filing date
60-Day Change
Pending
from filing date
Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT
PERPLEXITY
Turned Positive
GEMINI
Turned Positive
CLAUDE
Turned Positive
CHATGPT
Turned Positive
Unlock the Full Filing Analysis
See full earningsSig™ and risksSig™ analysis across 5,000+ companies
Get Started Free →No credit card required
Question:
What does Liquidia Corp actually do?
Answer:
Liquidia Corporation is a biopharmaceutical company focused on developing treatments for challenging respiratory and vascular diseases, primarily pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company's lead product, YUTREPIA (treprostinil) inhalation powder, utilizes proprietary PRINT technology for enhanced deep lung delivery and was approved by the FDA in May 2025 for both PAH and PH-ILD, commencing commercialization in June 2025. Liquidia also generates revenue through a profit-sharing agreement with Sandoz for generic treprostinil injection. The company is advancing its pipeline with L606, an investigational liposomal formulation of treprostinil, and is exploring additional indications for YUTREPIA.
Question:
What are Liquidia Corp's revenue drivers?
Answer:
Revenue is generated from the sale of YUTREPIA (treprostinil) inhalation powder and from profit sharing on Sandoz's generic treprostinil injection.
Cut through noisy SEC filings to find the signal faster
Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.
Get Started Free →No credit card required